Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 668,731,100
  • Shares Outstanding, K 9,750
  • 60-Month Beta 0.70
Trade IHE with:
  • Price/Earnings ttm 16.55
  • Annual Dividend & Yield 1.61 (2.34%)
  • Most Recent Dividend 0.294 on 06/11/24
  • Management Fee 0.39%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 4.03% ( +4.03%)
  • Historical Volatility 10.59%
  • IV Percentile 11%
  • IV Rank 11.32%
  • IV High 24.11% on 04/25/24
  • IV Low 1.46% on 07/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 19
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 50
  • Open Int (30-Day) 100

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.37 +5.78%
on 07/05/24
69.53 -0.54%
on 07/17/24
+2.13 (+3.18%)
since 06/26/24
3-Month
63.44 +9.00%
on 04/29/24
69.53 -0.54%
on 07/17/24
+5.84 (+9.22%)
since 04/26/24
52-Week
55.36 +24.90%
on 10/31/23
69.56 -0.59%
on 02/23/24
+8.33 (+13.70%)
since 07/26/23

Most Recent Stories

More News
Viatris Quarterly Earnings Preview: What You Need to Know

Viatris is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.

VTRS : 12.08 (+2.72%)
$SPX : 5,459.10 (+1.11%)
IHE : 69.15 (+0.76%)
Bristol-Myers Squibb's Q2 2024 Earnings: What to Expect

Bristol-Myers Squibb is poised to announce its second-quarter results this month, and analysts forecast a single-digit decline in the company’s bottom-line figure.

BMY : 50.45 (+11.44%)
$SPX : 5,459.10 (+1.11%)
IHE : 69.15 (+0.76%)
How Is Johnson & Johnson's Stock Performance Compared to Other Pharmaceutical Stocks?

Johnson & Johnson has recently underperformed other pharmaceutical stocks. However, Wall Street analysts are moderately optimistic about the stock’s prospects.

JNJ : 160.64 (+0.63%)
PFE : 30.77 (+3.39%)
IHE : 69.15 (+0.76%)
Do Wall Street Analysts Like Eli Lilly Stock?

Eli Lilly stock has outperformed the broader market over the past year, and Wall Street analysts remain optimistic about the stock’s prospect.

LLY : 804.62 (-2.02%)
$SPX : 5,459.10 (+1.11%)
IHE : 69.15 (+0.76%)
Are Wall Street Analysts Bullish on Viatris Stock?

Viatris has underperformed the broader market over the past year, and analysts remain cautious about the stock's prospects.

VTRS : 12.08 (+2.72%)
$SPX : 5,459.10 (+1.11%)
IHE : 69.15 (+0.76%)
Are Wall Street Analysts Bullish on Johnson & Johnson Stock?

As Johnson & Johnson trails the broader market, Wall Street analysts remain cautiously optimistic about the stock's prospects.

JNJ : 160.64 (+0.63%)
$SPX : 5,459.10 (+1.11%)
IHE : 69.15 (+0.76%)
C : 65.18 (+1.26%)
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?

Bristol-Myers Squibb stock has significantly trailed the broader market this year, and Wall Street remains wary on the stock’s prospects.

BMY : 50.45 (+11.44%)
$SPX : 5,459.10 (+1.11%)
IHE : 69.15 (+0.76%)
Worried About the Stock Market? Here Are 2 Safe Investments to Buy and Hold for Decades

These ETFs can balance stability and long-term growth.

IHE : 69.15 (+0.76%)
MOAT : 90.50 (+1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Key Turning Points

3rd Resistance Point 69.86
2nd Resistance Point 69.62
1st Resistance Point 69.39
Last Price 69.15
1st Support Level 68.91
2nd Support Level 68.67
3rd Support Level 68.44

See More

52-Week High 69.56
Last Price 69.15
Fibonacci 61.8% 64.14
Fibonacci 50% 62.46
Fibonacci 38.2% 60.79
52-Week Low 55.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar